When temps rise, so do medical risks. Should doctors and nurses talk more about heat?

True­Bind­ing, a Cal­i­for­nia start­up ad­dress­ing Alzheimer’s from a dif­fer­ent an­gle than most oth­er biotechs, has se­cured more than $50 mil­lion in ad­di­tion­al cap­i­tal. But it’s

Co­herus Bio­Sciences is mak­ing a small stock-for-stock trans­ac­tion to shore up its im­muno-on­col­o­gy pipeline in an ac­qui­si­tion of Sur­face On­col­o­gy that is val­ued at $65